Coherus / Junshi

Coherus / Junshi is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Coherus / Junshi products.

Drugs from Coherus / Junshi supported via NPP

BrandGenericCategoryIndication
LoqtorziPD‑1 inhibitorOncology (NPC)Nasopharyngeal carcinoma & other tumors

How NPP access to Coherus / Junshi products works

Reserve Meds sources Coherus / Junshi products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Coherus / Junshi

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Coherus / Junshi.

Start a request

Start a request for a Coherus / Junshi product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp